Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #5006
Reference
Drug alert no 17/2013
Name
Drug alert class 1 no 17: immediate [Gilead Sciences International Limited - AmBisome 50mg Powder for Solution for Infusion]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES;
Description
Gilead Sciences International Limited is recalling some batches as a precautionary measure due to a potential lack of sterility assurance. No complaints or adverse reaction reports which may be related to this issue have been received by the company to date.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy and Medicines Division, Finance, e-Health and Pharmaceuticals Directorate, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2013-06-18 00:00:00
Click to go back to homepage